Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases
about
Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndromeAutoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic valueA new target for autoantibodies in patients with rheumatoid arthritis.Overexpression of a minimal domain of calpastatin suppresses IL-6 production and Th17 development via reduced NF-κB and increased STAT5 signalsCellular adhesion gene SELP is associated with rheumatoid arthritis and displays differential allelic expression.Analysis of in vivo role of alpha-fodrin autoantigen in primary Sjogren's syndromeSerum samples of patients with rheumatoid arthritis contain a specific autoantibody to "denatured" aldolase A in the osteoblast-like cell line, MG-63Diagnostic and prognostic significance of autoantibodies in early rheumatoid arthritis.Biomarkers of rheumatoid arthritis: recent progress.Antibodies to native and citrullinated RA33 (hnRNP A2/B1) challenge citrullination as the inciting principle underlying loss of tolerance in rheumatoid arthritis.Amelioration of experimental arthritis by a calpain-inhibitory compound: regulation of cytokine production by E-64-d in vivo and in vitro.Cloning of novel soluble gp130 and detection of its neutralizing autoantibodies in rheumatoid arthritisAutoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis.Domain reactivity of autoantibodies to calpastatin in patients with systemic rheumatic diseases.Autoantibodies directed against the protease inhibitor calpastatin in psoriasis.
P2860
Q24684545-B6CDBD87-7D1A-464B-A6E3-629D2FC0B79BQ24806041-FFA855F0-A276-4461-9AE5-ACFB35D1554AQ33300254-9DBAA5B9-A69F-48A3-9273-5DA5586DB236Q34064908-709DDC57-5AD7-4DE2-841D-8529748325ACQ34078388-7511B492-5024-42EB-9D05-357847F4BE3CQ35085204-3B231306-0886-4349-B2EE-3C32B0971D8CQ35548485-06A9A564-31C9-40D4-9547-9EFEA0151663Q36226393-915E7053-955D-4ECF-83FE-A76540AEBB14Q38089869-960AB93B-1F84-42E5-BAE8-BDF86820AD64Q40005980-EA710EF0-5151-461D-B411-D4F7A1FDB64CQ40370472-4188B16E-08BC-4408-A647-62827C044AE5Q40432069-B2DF2775-EBE3-46FB-9F60-509431394E6EQ41824468-C9CBF358-17E8-4B7A-A4FD-C735CC2E892FQ47703012-9E3E4F5A-F123-48F1-A65D-8B5D7219B9DEQ53802318-21158607-E639-49AA-8D84-3F58F4993F33
P2860
Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases
description
1995 nî lūn-bûn
@nan
1995 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Autoantibodies to calpastatin ...... in systemic rheumatic diseases
@ast
Autoantibodies to calpastatin ...... in systemic rheumatic diseases
@en
Autoantibodies to calpastatin ...... in systemic rheumatic diseases
@en-gb
Autoantibodies to calpastatin ...... in systemic rheumatic diseases
@nl
type
label
Autoantibodies to calpastatin ...... in systemic rheumatic diseases
@ast
Autoantibodies to calpastatin ...... in systemic rheumatic diseases
@en
Autoantibodies to calpastatin ...... in systemic rheumatic diseases
@en-gb
Autoantibodies to calpastatin ...... in systemic rheumatic diseases
@nl
prefLabel
Autoantibodies to calpastatin ...... in systemic rheumatic diseases
@ast
Autoantibodies to calpastatin ...... in systemic rheumatic diseases
@en
Autoantibodies to calpastatin ...... in systemic rheumatic diseases
@en-gb
Autoantibodies to calpastatin ...... in systemic rheumatic diseases
@nl
P2093
P2860
P921
P356
P1476
Autoantibodies to calpastatin ...... in systemic rheumatic diseases
@en
P2093
K Suganuma
M Matsumura
T Yoshizawa
P2860
P304
P356
10.1073/PNAS.92.16.7267
P407
P577
1995-08-01T00:00:00Z